Φορτώνει......
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concern...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cochrane Database Syst Rev |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Ltd
2021
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092433/ https://ncbi.nlm.nih.gov/pubmed/33857326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|